▶ 調査レポート

市販用(OTC)鎮痛剤の世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Over the Counter (OTC) Analgesics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。市販用(OTC)鎮痛剤の世界市場2020年:メーカー別、地域別、種類・用途別 / Global Over the Counter (OTC) Analgesics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D0GIR-11423資料のイメージです。• レポートコード:D0GIR-11423
• 出版社/出版日:GlobalInfoResearch / 2020年9月23日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、市販用(OTC)鎮痛剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。市販用(OTC)鎮痛剤の種類別市場規模(タブレット、カプセル、その他)、用途別市場規模(小売薬局、病院薬局、オンライン薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Pfizer、GlaxoSmithKline PLC、Novartis、Johnson & Johnson、Boehringer Ingelheim International GmbH、AstraZeneca、Sanofi SA、Bayer AG、Sun Pharma、Reckitt Benckiser Group PLC、Takeda Pharmaceutical Company Limited.
・地域別グローバル市場分析 2015年-2020年
・市販用(OTC)鎮痛剤の北米市場(アメリカ、カナダ、メキシコ)
・市販用(OTC)鎮痛剤のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・市販用(OTC)鎮痛剤のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・市販用(OTC)鎮痛剤の南米市場(ブラジル、アルゼンチン)
・市販用(OTC)鎮痛剤の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:タブレット、カプセル、その他
・用途別分析:小売薬局、病院薬局、オンライン薬局
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The Over the Counter (OTC) Analgesics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Over the Counter (OTC) Analgesics sales will be xx in 2020 from Over the Counter (OTC) Analgesics million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Over the Counter (OTC) Analgesics market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Over the Counter (OTC) Analgesics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Over the Counter (OTC) Analgesics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Over the Counter (OTC) Analgesics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Over the Counter (OTC) Analgesics market has been segmented into
Tablet
Capsule
Other

By Application, Over the Counter (OTC) Analgesics has been segmented into:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Over the Counter (OTC) Analgesics market presented in the report. This section sheds light on the sales growth of different regional and country-level Over the Counter (OTC) Analgesics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Over the Counter (OTC) Analgesics market.

The report offers in-depth assessment of the growth and other aspects of the Over the Counter (OTC) Analgesics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Over the Counter (OTC) Analgesics Market Share Analysis
Over the Counter (OTC) Analgesics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Over the Counter (OTC) Analgesics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Over the Counter (OTC) Analgesics sales, revenue and market share for each player covered in this report.

The major players covered in Over the Counter (OTC) Analgesics are:
Pfizer
GlaxoSmithKline PLC
Novartis
Johnson & Johnson
Boehringer Ingelheim International GmbH
AstraZeneca
Sanofi SA
Bayer AG
Sun Pharma
Reckitt Benckiser Group PLC
Takeda Pharmaceutical Company Limited.

Among other players domestic and global, Over the Counter (OTC) Analgesics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Over the Counter (OTC) Analgesics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Over the Counter (OTC) Analgesics, with price, sales, revenue and global market share of Over the Counter (OTC) Analgesics in 2018 and 2019.
Chapter 3, the Over the Counter (OTC) Analgesics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Over the Counter (OTC) Analgesics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Over the Counter (OTC) Analgesics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Over the Counter (OTC) Analgesics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Over the Counter (OTC) Analgesics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Over the Counter (OTC) Analgesics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Over the Counter (OTC) Analgesics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Overview of Global Over the Counter (OTC) Analgesics Market
1.4.1 Global Over the Counter (OTC) Analgesics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Over the Counter (OTC) Analgesics Industry Impact
1.6.1 COVID-19 Potential Implications for the Over the Counter (OTC) Analgesics
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Over the Counter (OTC) Analgesics
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline PLC
2.2.1 GlaxoSmithKline PLC Details
2.2.2 GlaxoSmithKline PLC Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline PLC SWOT Analysis
2.2.4 GlaxoSmithKline PLC Product and Services
2.2.5 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Boehringer Ingelheim International GmbH
2.5.1 Boehringer Ingelheim International GmbH Details
2.5.2 Boehringer Ingelheim International GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Boehringer Ingelheim International GmbH SWOT Analysis
2.5.4 Boehringer Ingelheim International GmbH Product and Services
2.5.5 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sanofi SA
2.7.1 Sanofi SA Details
2.7.2 Sanofi SA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sanofi SA SWOT Analysis
2.7.4 Sanofi SA Product and Services
2.7.5 Sanofi SA Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bayer AG
2.8.1 Bayer AG Details
2.8.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bayer AG SWOT Analysis
2.8.4 Bayer AG Product and Services
2.8.5 Bayer AG Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sun Pharma SWOT Analysis
2.9.4 Sun Pharma Product and Services
2.9.5 Sun Pharma Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Reckitt Benckiser Group PLC
2.10.1 Reckitt Benckiser Group PLC Details
2.10.2 Reckitt Benckiser Group PLC Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Reckitt Benckiser Group PLC SWOT Analysis
2.10.4 Reckitt Benckiser Group PLC Product and Services
2.10.5 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Takeda Pharmaceutical Company Limited.
2.11.1 Takeda Pharmaceutical Company Limited. Details
2.11.2 Takeda Pharmaceutical Company Limited. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Takeda Pharmaceutical Company Limited. SWOT Analysis
2.11.4 Takeda Pharmaceutical Company Limited. Product and Services
2.11.5 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Over the Counter (OTC) Analgesics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Over the Counter (OTC) Analgesics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Over the Counter (OTC) Analgesics Manufacturer Market Share in 2019
3.3.2 Top 6 Over the Counter (OTC) Analgesics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Over the Counter (OTC) Analgesics Sales, Revenue and Market Share by Regions
4.1.1 Global Over the Counter (OTC) Analgesics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Over the Counter (OTC) Analgesics Revenue and Market Share by Regions (2015-2020)
4.2 North America Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
4.3 Europe Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
4.5 South America Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Over the Counter (OTC) Analgesics Sales, Revenue and Market Share by Country
5.1.1 North America Over the Counter (OTC) Analgesics Sales and Market Share by Country (2015-2020)
5.1.2 North America Over the Counter (OTC) Analgesics Revenue and Market Share by Country (2015-2020)
5.2 United States Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
5.3 Canada Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
5.4 Mexico Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Over the Counter (OTC) Analgesics Sales, Revenue and Market Share by Country
6.1.1 Europe Over the Counter (OTC) Analgesics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Over the Counter (OTC) Analgesics Revenue and Market Share by Country (2015-2020)
6.2 Germany Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
6.3 UK Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
6.4 France Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
6.5 Russia Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
6.6 Italy Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Over the Counter (OTC) Analgesics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Over the Counter (OTC) Analgesics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Over the Counter (OTC) Analgesics Revenue and Market Share by Regions (2015-2020)
7.2 China Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
7.3 Japan Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
7.4 Korea Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
7.5 India Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
7.7 Australia Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Over the Counter (OTC) Analgesics Sales, Revenue and Market Share by Country
8.1.1 South America Over the Counter (OTC) Analgesics Sales and Market Share by Country (2015-2020)
8.1.2 South America Over the Counter (OTC) Analgesics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
8.3 Argentina Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Over the Counter (OTC) Analgesics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Over the Counter (OTC) Analgesics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Over the Counter (OTC) Analgesics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
9.3 Turkey Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
9.4 Egypt Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
9.5 South Africa Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Over the Counter (OTC) Analgesics Sales and Market Share by Type (2015-2020)
10.2 Global Over the Counter (OTC) Analgesics Revenue and Market Share by Type (2015-2020)
10.3 Global Over the Counter (OTC) Analgesics Price by Type (2015-2020)
11 Global Over the Counter (OTC) Analgesics Market Segment by Application
11.1 Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2015-2020)
11.2 Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2015-2020)
11.3 Global Over the Counter (OTC) Analgesics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Over the Counter (OTC) Analgesics Sales, Revenue and Growth Rate (2021-2025)
12.2 Over the Counter (OTC) Analgesics Market Forecast by Regions (2021-2025)
12.2.1 North America Over the Counter (OTC) Analgesics Market Forecast (2021-2025)
12.2.2 Europe Over the Counter (OTC) Analgesics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Over the Counter (OTC) Analgesics Market Forecast (2021-2025)
12.2.4 South America Over the Counter (OTC) Analgesics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Over the Counter (OTC) Analgesics Market Forecast (2021-2025)
12.3 Over the Counter (OTC) Analgesics Market Forecast by Type (2021-2025)
12.3.1 Global Over the Counter (OTC) Analgesics Sales Forecast by Type (2021-2025)
12.3.2 Global Over the Counter (OTC) Analgesics Market Share Forecast by Type (2021-2025)
12.4 Over the Counter (OTC) Analgesics Market Forecast by Application (2021-2025)
12.4.1 Global Over the Counter (OTC) Analgesics Sales Forecast by Application (2021-2025)
12.4.2 Global Over the Counter (OTC) Analgesics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Over the Counter (OTC) Analgesics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Over the Counter (OTC) Analgesics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Over the Counter (OTC) Analgesics Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Over the Counter (OTC) Analgesics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Over the Counter (OTC) Analgesics Major Business
Table 10. Pfizer Over the Counter (OTC) Analgesics Total Revenue (USD Million) (2018-2019)
Table 11. Pfizer SWOT Analysis
Table 12. Pfizer Over the Counter (OTC) Analgesics Product and Services
Table 13. Pfizer Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. GlaxoSmithKline PLC Basic Information, Manufacturing Base and Competitors
Table 15. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Major Business
Table 16. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Total Revenue (USD Million) (2018-2019)
Table 17. GlaxoSmithKline PLC SWOT Analysis
Table 18. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product and Services
Table 19. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Novartis Basic Information, Manufacturing Base and Competitors
Table 21. Novartis Over the Counter (OTC) Analgesics Major Business
Table 22. Novartis Over the Counter (OTC) Analgesics Total Revenue (USD Million) (2018-2019)
Table 23. Novartis SWOT Analysis
Table 24. Novartis Over the Counter (OTC) Analgesics Product and Services
Table 25. Novartis Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 27. Johnson & Johnson Over the Counter (OTC) Analgesics Major Business
Table 28. Johnson & Johnson Over the Counter (OTC) Analgesics Total Revenue (USD Million) (2018-2019)
Table 29. Johnson & Johnson SWOT Analysis
Table 30. Johnson & Johnson Over the Counter (OTC) Analgesics Product and Services
Table 31. Johnson & Johnson Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 33. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Major Business
Table 34. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Total Revenue (USD Million) (2018-2019)
Table 35. Boehringer Ingelheim International GmbH SWOT Analysis
Table 36. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product and Services
Table 37. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Over the Counter (OTC) Analgesics Major Business
Table 40. AstraZeneca Over the Counter (OTC) Analgesics Total Revenue (USD Million) (2018-2019)
Table 41. AstraZeneca SWOT Analysis
Table 42. AstraZeneca Over the Counter (OTC) Analgesics Product and Services
Table 43. AstraZeneca Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Sanofi SA Basic Information, Manufacturing Base and Competitors
Table 45. Sanofi SA Over the Counter (OTC) Analgesics Major Business
Table 46. Sanofi SA Over the Counter (OTC) Analgesics Total Revenue (USD Million) (2018-2019)
Table 47. Sanofi SA SWOT Analysis
Table 48. Sanofi SA Over the Counter (OTC) Analgesics Product and Services
Table 49. Sanofi SA Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 51. Bayer AG Over the Counter (OTC) Analgesics Major Business
Table 52. Bayer AG Over the Counter (OTC) Analgesics Total Revenue (USD Million) (2018-2019)
Table 53. Bayer AG SWOT Analysis
Table 54. Bayer AG Over the Counter (OTC) Analgesics Product and Services
Table 55. Bayer AG Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 57. Sun Pharma Over the Counter (OTC) Analgesics Major Business
Table 58. Sun Pharma Over the Counter (OTC) Analgesics Total Revenue (USD Million) (2018-2019)
Table 59. Sun Pharma SWOT Analysis
Table 60. Sun Pharma Over the Counter (OTC) Analgesics Product and Services
Table 61. Sun Pharma Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Reckitt Benckiser Group PLC Basic Information, Manufacturing Base and Competitors
Table 63. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Major Business
Table 64. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Total Revenue (USD Million) (2018-2019)
Table 65. Reckitt Benckiser Group PLC SWOT Analysis
Table 66. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product and Services
Table 67. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Takeda Pharmaceutical Company Limited. Basic Information, Manufacturing Base and Competitors
Table 69. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Major Business
Table 70. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Total Revenue (USD Million) (2018-2019)
Table 71. Takeda Pharmaceutical Company Limited. SWOT Analysis
Table 72. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product and Services
Table 73. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Global Over the Counter (OTC) Analgesics Sales by Manufacturer (2018-2019) (K Units)
Table 75. Global Over the Counter (OTC) Analgesics Revenue by Manufacturer (2018-2019) (USD Million)
Table 76. Global Over the Counter (OTC) Analgesics Sales by Regions (2015-2020) (K Units)
Table 77. Global Over the Counter (OTC) Analgesics Sales Market Share by Regions (2015-2020)
Table 78. Global Over the Counter (OTC) Analgesics Revenue by Regions (2015-2020) (USD Million)
Table 79. North America Over the Counter (OTC) Analgesics Sales by Countries (2015-2020) (K Units)
Table 80. North America Over the Counter (OTC) Analgesics Sales Market Share by Countries (2015-2020)
Table 81. North America Over the Counter (OTC) Analgesics Revenue by Countries (2015-2020) (USD Million)
Table 82. North America Over the Counter (OTC) Analgesics Revenue Market Share by Countries (2015-2020)
Table 83. Europe Over the Counter (OTC) Analgesics Sales by Countries (2015-2020) (K Units)
Table 84. Europe Over the Counter (OTC) Analgesics Sales Market Share by Countries (2015-2020)
Table 85. Europe Over the Counter (OTC) Analgesics Revenue by Countries (2015-2020) (USD Million)
Table 86. Asia-Pacific Over the Counter (OTC) Analgesics Sales by Regions (2015-2020) (K Units)
Table 87. Asia-Pacific Over the Counter (OTC) Analgesics Sales Market Share by Regions (2015-2020)
Table 88. Asia-Pacific Over the Counter (OTC) Analgesics Revenue by Regions (2015-2020) (USD Million)
Table 89. South America Over the Counter (OTC) Analgesics Sales by Countries (2015-2020) (K Units)
Table 90. South America Over the Counter (OTC) Analgesics Sales Market Share by Countries (2015-2020)
Table 91. South America Over the Counter (OTC) Analgesics Revenue by Countries (2015-2020) (USD Million)
Table 92. South America Over the Counter (OTC) Analgesics Revenue Market Share by Countries (2015-2020)
Table 93. Middle East & Africa Over the Counter (OTC) Analgesics Sales by Countries (2015-2020) (K Units)
Table 94. Middle East & Africa Over the Counter (OTC) Analgesics Sales Market Share by Countries (2015-2020)
Table 95. Middle East & Africa Over the Counter (OTC) Analgesics Revenue by Countries (2015-2020) (USD Million)
Table 96. Middle East & Africa Over the Counter (OTC) Analgesics Revenue Market Share by Countries (2015-2020)
Table 97. Global Over the Counter (OTC) Analgesics Sales by Type (2015-2020) (K Units)
Table 98. Global Over the Counter (OTC) Analgesics Sales Share by Type (2015-2020)
Table 99. Global Over the Counter (OTC) Analgesics Revenue by Type (2015-2020) (USD Million)
Table 100. Global Over the Counter (OTC) Analgesics Revenue Share by Type (2015-2020)
Table 101. Global Over the Counter (OTC) Analgesics Sales by Application (2015-2020) (K Units)
Table 102. Global Over the Counter (OTC) Analgesics Sales Share by Application (2015-2020)
Table 103. Global Over the Counter (OTC) Analgesics Sales Forecast by Regions (2021-2025) (K Units)
Table 104. Global Over the Counter (OTC) Analgesics Market Share Forecast by Regions (2021-2025)
Table 105. Global Over the Counter (OTC) Analgesics Sales Forecast by Type (2021-2025) (K Units)
Table 106. Global Over the Counter (OTC) Analgesics Market Share Forecast by Type (2021-2025)
Table 107. Global Over the Counter (OTC) Analgesics Sales Forecast by Application (2021-2025)
Table 108. Global Over the Counter (OTC) Analgesics Market Share Forecast by Application (2021-2025)
Table 109. Direct Channel Pros & Cons
Table 110. Indirect Channel Pros & Cons
Table 111. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Over the Counter (OTC) Analgesics Picture
Figure 2. Global Sales Market Share of Over the Counter (OTC) Analgesics by Type in 2019
Figure 3. Tablet Picture
Figure 4. Capsule Picture
Figure 5. Other Picture
Figure 6. Over the Counter (OTC) Analgesics Sales Market Share by Application in 2018
Figure 7. Retail Pharmacies Picture
Figure 8. Hospital Pharmacies Picture
Figure 9. Online Pharmacies Picture
Figure 10. Global Over the Counter (OTC) Analgesics Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Over the Counter (OTC) Analgesics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Over the Counter (OTC) Analgesics Sales Market Share by Manufacturer in 2019
Figure 31. Global Over the Counter (OTC) Analgesics Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Over the Counter (OTC) Analgesics Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Over the Counter (OTC) Analgesics Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Over the Counter (OTC) Analgesics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Over the Counter (OTC) Analgesics Revenue Market Share by Regions (2015-2020)
Figure 38. Global Over the Counter (OTC) Analgesics Revenue Market Share by Regions in 2018
Figure 39. North America Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
Figure 40. Europe Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
Figure 42. South America Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020)
Figure 44. North America Over the Counter (OTC) Analgesics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Over the Counter (OTC) Analgesics Sales Market Share by Countries (2015-2020)
Figure 46. North America Over the Counter (OTC) Analgesics Sales Market Share by Countries in 2018
Figure 47. North America Over the Counter (OTC) Analgesics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Over the Counter (OTC) Analgesics Revenue Market Share by Countries in 2018
Figure 49. United States Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Over the Counter (OTC) Analgesics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Over the Counter (OTC) Analgesics Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Over the Counter (OTC) Analgesics Revenue Market Share by Countries in 2019
Figure 55. Germany Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Over the Counter (OTC) Analgesics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Over the Counter (OTC) Analgesics Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Over the Counter (OTC) Analgesics Revenue Market Share by Regions 2019
Figure 63. China Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Over the Counter (OTC) Analgesics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Over the Counter (OTC) Analgesics Sales Market Share by Countries in 2019
Figure 70. South America Over the Counter (OTC) Analgesics Revenue Market Share by Countries in 2019
Figure 71. Brazil Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Over the Counter (OTC) Analgesics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Over the Counter (OTC) Analgesics Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Over the Counter (OTC) Analgesics Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Over the Counter (OTC) Analgesics Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Over the Counter (OTC) Analgesics Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Over the Counter (OTC) Analgesics Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Over the Counter (OTC) Analgesics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Over the Counter (OTC) Analgesics Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Over the Counter (OTC) Analgesics Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Over the Counter (OTC) Analgesics Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Over the Counter (OTC) Analgesics Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Over the Counter (OTC) Analgesics Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel